Seaport Therapeutics completes IPO, Class A common stock capital structure (full multi-class details, if any, are in the charter exhibit / prospectus — not disclosed in this filing body) with 700M shares

Filed May 4, 2026 · Period ending May 4, 2026 · ~1 min read

Key Changes

• high

  Company authorized 700 million common shares split between 500 million voting and 200 million non-voting shares, creating a Class A common stock capital structure (full multi-class details, if any, are in the charter exhibit / prospectus — not disclosed in this filing body) that concentrates voting control with certain shareholders.

  Item 5.03 verify on EDGAR →
• medium

  Board authorized 10 million undesignated preferred shares that can be issued without shareholder approval, giving management flexibility for future capital raises or defensive measures.

  Item 5.03 verify on EDGAR →
• low

  Company eliminated all prior preferred stock series and filed amended certificate of incorporation with Delaware as part of standard IPO process.

  Item 5.03 verify on EDGAR →